Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445–1457. https://doi.org/10.1016/S0140-6736(13)60178-6
Article CAS PubMed Central Google Scholar
Chen J, Stahl A, Hellstrom A, Smith LE (2011) Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 23(2):173–178. https://doi.org/10.1097/MOP.0b013e3283423f35
Article CAS PubMed PubMed Central Google Scholar
Enriquez AB, Avery RL, Baumal CR (2020) Update on anti-vascular endothelial growth factor safety for retinopathy of prematurity. Asia Pac J Ophthalmol (Phila) 9(4):358–368. https://doi.org/10.1097/APO.0000000000000302
Hansen RM, Moskowitz A, Akula JD, Fulton AB (2017) The neural retina in retinopathy of prematurity. Prog Retin Eye Res 56:32–57. https://doi.org/10.1016/j.preteyeres.2016.09.004
Article CAS PubMed Google Scholar
Fu Z, Nilsson AK, Hellstrom A, Smith LEH (2022) Retinopathy of prematurity: Metabolic risk factors. Elife. https://doi.org/10.7554/eLife.80550
Article PubMed PubMed Central Google Scholar
Au SC, Tang SM, Rong SS, Chen LJ, Yam JC (2015) Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis. Sci Rep 5:9091. https://doi.org/10.1038/srep09091
Article CAS PubMed PubMed Central Google Scholar
Ahmadpour-Kacho M, Motlagh AJ, Rasoulinejad SA, Jahangir T, Bijani A, Pasha YZ (2014) Correlation between hyperglycemia and retinopathy of prematurity. Pediatr Int 56(5):726–730. https://doi.org/10.1111/ped.12371
Garg R, Agthe AG, Donohue PK, Lehmann CU (2003) Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol 23(3):186–194. https://doi.org/10.1038/sj.jp.7210879
Mohamed S, Murray JC, Dagle JM, Colaizy T (2013) Hyperglycemia as a risk factor for the development of retinopathy of prematurity. BMC Pediatr 13:78. https://doi.org/10.1186/1471-2431-13-78
Article PubMed PubMed Central Google Scholar
Kaempf JW, Kaempf AJ, Wu Y, Stawarz M, Niemeyer J, Grunkemeier G (2011) Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol 31(4):251–257. https://doi.org/10.1038/jp.2010.152
Article CAS PubMed Google Scholar
Mohsen L, Abou-Alam M, El-Dib M, Labib M, Elsada M, Aly H (2014) A prospective study on hyperglycemia and retinopathy of prematurity. J Perinatol 34(6):453–457. https://doi.org/10.1038/jp.2014.49
Article CAS PubMed Google Scholar
Ertl T, Gyarmati J, Gaal V, Szabo I (2006) Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 89(1):56–59. https://doi.org/10.1159/000088199
Chavez-Valdez R, McGowan J, Cannon E, Lehmann CU (2011) Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants. J Perinatol 31(12):749–756. https://doi.org/10.1038/jp.2011.19
Blanco CL, Baillargeon JG, Morrison RL, Gong AK (2006) Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 26(12):737–741. https://doi.org/10.1038/sj.jp.7211594
Article CAS PubMed Google Scholar
Fu Z, Lofqvist CA, Liegl R, Wang Z, Sun Y, Gong Y, Liu CH, Meng SS, Burnim SB, Arellano I, Chouinard MT, Duran R, Poblete A, Cho SS, Akula JD, Kinter M, Ley D, Pupp IH, Talukdar S, Hellstrom A, Smith LE (2018) Photoreceptor glucose metabolism determines normal retinal vascular growth. EMBO Mol Med 10(1):76–90. https://doi.org/10.15252/emmm.201707966
Article CAS PubMed Google Scholar
Kajantie E, Hytinantti T, Hovi P, Andersson S (2004) Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab 89(8):4031–4036. https://doi.org/10.1210/jc.2004-0018
Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26(8):2442–2450
Article CAS PubMed Google Scholar
Klamer A, Skogstrand K, Hougaard DM, Norgaard-Petersen B, Juul A, Greisen G (2007) Adiponectin levels measured in dried blood spot samples from neonates born small and appropriate for gestational age. Eur J Endocrinol 157(2):189–194. https://doi.org/10.1530/EJE-06-0710
Article CAS PubMed Google Scholar
Hansen-Pupp I, Hellgren G, Hard AL, Smith L, Hellstrom A, Lofqvist C (2015) Early surge in circulatory adiponectin is associated with improved growth at near term in very preterm infants. J Clin Endocrinol Metab 100(6):2380–2387. https://doi.org/10.1210/jc.2015-1081
Article CAS PubMed Google Scholar
Saito M, Nishimura K, Nozue H, Miyazono Y, Kamoda T (2011) Changes in serum adiponectin levels from birth to term-equivalent age are associated with postnatal weight gain in preterm infants. Neonatology 100(1):93–98
Article CAS PubMed Google Scholar
Siahanidou T, Mandyla H, Papassotiriou GP, Papassotiriou I, Chrousos G (2007) Circulating levels of adiponectin in preterm infants. Arch Dis Child Fetal Neonatal Ed 92(4):F286-290. https://doi.org/10.1136/adc.2006.106112
Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A (2004) Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 56(5):690–693. https://doi.org/10.1203/01.PDR.0000142711.24999.8A
Article CAS PubMed Google Scholar
Fu Z, Yan W, Chen CT, Nilsson AK, Bull E, Allen W, Yang J, Ko M, SanGiovanni JP, Akula JD, Talukdar S, Hellstrom A, Smith LEH (2022) Omega-3/Omega-6 long-chain fatty acid imbalance in phase i retinopathy of prematurity. Nutrients 14(7):1333. https://doi.org/10.3390/nu14071333
Article CAS PubMed PubMed Central Google Scholar
Fu Z, Gong Y, Lofqvist C, Hellstrom A, Smith LE (2016) Review: adiponectin in retinopathy. Biochem Biophys Acta 1862(8):1392–1400. https://doi.org/10.1016/j.bbadis.2016.05.002
Article CAS PubMed Google Scholar
Holland WL, Adams AC, Brozinick JT, Bui HH, Miyauchi Y, Kusminski CM, Bauer SM, Wade M, Singhal E, Cheng CC, Volk K, Kuo MS, Gordillo R, Kharitonenkov A, Scherer PE (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17(5):790–797. https://doi.org/10.1016/j.cmet.2013.03.019
Article CAS PubMed PubMed Central Google Scholar
Talukdar S, Zhou Y, Li D, Rossulek M, Dong J, Somayaji V, Weng Y, Clark R, Lanba A, Owen BM, Brenner MB, Trimmer JK, Gropp KE, Chabot JR, Erion DM, Rolph TP, Goodwin B, Calle RA (2016) A Long-Acting FGF21 Molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects. Cell Metab 23(3):427–440. https://doi.org/10.1016/j.cmet.2016.02.001
Article CAS PubMed Google Scholar
Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, Mohammadi M, Potthoff MJ (2014) Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63(12):4057–4063. https://doi.org/10.2337/db14-0595
Article CAS PubMed PubMed Central Google Scholar
Sanchez-Infantes D, Gallego-Escuredo JM, Diaz M, Aragones G, Sebastiani G, Lopez-Bermejo A, de Zegher F, Domingo P, Villarroya F, Ibanez L (2015) Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations. Int J Obes (Lond) 39(5):742–746. https://doi.org/10.1038/ijo.2015.2
Article CAS PubMed Google Scholar
Guasti L, Silvennoinen S, Bulstrode NW, Ferretti P, Sankilampi U, Dunkel L (2014) Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes. J Clin Endocrinol Metab 99(11):E2198-2206. https://doi.org/10.1210/jc.2014-1566
Article CAS PubMed Google Scholar
Mericq V, De Luca F, Hernandez MI, Pena V, Rossel K, Garcia M, Avila A, Cavada G, Iniguez G (2014) Serum fibroblast growth factor 21 levels are inversely associated with growth rates in infancy. Horm Res Paediatr 82(5):324–331. https://doi.org/10.1159/000367922
Article CAS PubMed Google Scholar
Joung KE, Clausen D, Herdt A, Presti A, Snyder R, Peters C, Christou H, Mantzoros CS (2020) Association of circulating FGF-21 levels in the first week of life and postnatal growth in hospitalized preterm infants. Metabol Open 5:100030. https://doi.org/10.1016/j.metop.2020.100030
Article PubMed PubMed Central Google Scholar
Megia A, Gil-Lluis P, Naf S, Ceperuelo-Mallafre V, Gonzalez-Clemente JM, Llaurado G, Nunez-Roa C, Roche K, Ballesteros M, Yanez RE, Fernandez-Veledo S, Vendrell J (2015) Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth. Acta Diabetol 52(4):693–700. https://doi.org/10.1007/s00592-014-0705-9
Fazeli PK, Lun M, Kim SM, Bredella MA, Wright S, Zhang Y, Lee H, Catana C, Klibanski A, Patwari P, Steinhauser ML (2015) FGF21 and the late adaptive response to starvation in humans. J Clin Investig 125(12):4601–4611. https://doi.org/10.1172/JCI83349
Article PubMed Central Google Scholar
Wu, C., Löfqvist, C., Smith, L.E., VanderVeen, D.K., Hellström, A. and WINROP Consortium, F.T (2012) Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol 130(8):992–999. https://doi.org/10.1001/archophthalmol.2012.243
Athikarisamy S, Desai S, Patole S, Rao S, Simmer K, Lam GC (2021) The use of postnatal weight gain algorithms to predict severe or type 1 retinopathy of prematurity: a systematic review and meta-analysis. JAMA Netw
Comments (0)